Ohio Public Employees Retirement System (OPERS)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4M Sell
37,998
-6,024
-14% -$1.82M 0.03% 426
2026
Q1
$14.6M Sell
44,022
-476
-1% -$162K 0.05% 337
2025
Q4
$17.7M Buy
44,498
+5,504
+14% +$2.44M 0.06% 297
2025
Q3
$17.8M Buy
38,994
+242
+0.6% +$98.5K 0.06% 299
2025
Q2
$12.6M Sell
38,752
-917
-2% -$254K 0.04% 370
2025
Q1
$10.7M Sell
39,669
-4,588
-10% -$1.18M 0.04% 401
2024
Q4
$10.4M Sell
44,257
-4,180
-9% -$1.1M 0.04% 418
2024
Q3
$13.3M Sell
48,437
-3,275
-6% -$853K 0.06% 327
2024
Q2
$12.6M Buy
51,712
+164
+0.3% +$25.9K 0.05% 316
2024
Q1
$7.7M Sell
51,548
-3,869
-7% -$645K 0.03% 458
2023
Q4
$10.6M Buy
55,417
+747
+1% +$127K 0.04% 365
2023
Q3
$9.68M Sell
54,670
-5,588
-9% -$1.07M 0.04% 358
2023
Q2
$11.4M Sell
60,258
-5,091
-8% -$1.01M 0.05% 351
2023
Q1
$13.1M Sell
65,349
-2,750
-4% -$578K 0.05% 328
2022
Q4
$16.2M Buy
68,099
+6,707
+11% +$1.43M 0.07% 272
2022
Q3
$12.3M Buy
61,392
+244
+0.4% +$46.5K 0.06% 326
2022
Q2
$8.92M Sell
61,148
-2,213
-3% -$314K 0.04% 410
2022
Q1
$10.3M Sell
63,361
-1,430
-2% -$218K 0.04% 439
2021
Q4
$11M Sell
64,791
-2,219
-3% -$412K 0.04% 434
2021
Q3
$12.7M Buy
67,010
+49
+0.1% +$9.19K 0.05% 380
2021
Q2
$11.4M Buy
66,961
+4,712
+8% +$690K 0.04% 424
2021
Q1
$8.79M Buy
62,249
+5,516
+10% +$830K 0.03% 464
2020
Q4
$7.37M Buy
56,733
+10,936
+24% +$1.46M 0.03% 478
2020
Q3
$6.67M Buy
45,797
+2,201
+5% +$313K 0.04% 393
2020
Q2
$6.46M Buy
43,596
+684
+2% +$92.2K 0.04% 437
2020
Q1
$4.67M Buy
42,912
+6,922
+19% +$799K 0.03% 481
2019
Q4
$4.14M Sell
35,990
-1,083
-3% -$108K 0.02% 622
2019
Q3
$2.98M Buy
37,073
+88
+0.2% +$6.96K 0.02% 793
2019
Q2
$2.68M Buy
36,985
+1,680
+5% +$129K 0.01% 842
2019
Q1
$3.3M Buy
35,305
+2,017
+6% +$169K 0.02% 767
2018
Q4
$2.43M Sell
33,288
-2,607
-7% -$201K 0.01% 822
2018
Q3
$3.14M Sell
35,895
-288
-0.8% -$29K 0.02% 833
2018
Q2
$3.56M Sell
36,183
-642
-2% -$63.7K 0.02% 791
2018
Q1
$4.39M Sell
36,825
-366
-1% -$47.2K 0.02% 671
2017
Q4
$4.72M Buy
37,191
+4,311
+13% +$542K 0.02% 682
2017
Q3
$3.86M Buy
32,880
+1,026
+3% +$87.6K 0.02% 733
2017
Q2
$2.54M Sell
31,854
-657
-2% -$42K 0.01% 868
2017
Q1
$1.67M Hold
32,511
0.01% 1026
2016
Q4
$1.49M Buy
32,511
+136
+0.4% +$5.69K 0.01% 1075
2016
Q3
$2.19M Buy
32,375
+3,414
+12% +$241K 0.01% 864
2016
Q2
$1.61M Buy
28,961
+1,000
+4% +$63K 0.01% 952
2016
Q1
$1.75M Sell
27,961
-14,878
-35% -$989K 0.01% 879
2015
Q4
$4.03M Buy
42,839
+6,145
+17% +$570K 0.02% 551
2015
Q3
$2.95M Sell
36,694
-4,622
-11% -$514K 0.02% 695
2015
Q2
$4.95M Buy
41,316
+1,369
+3% +$164K 0.03% 568
2015
Q1
$4.17M Sell
39,947
-11,965
-23% -$1.21M 0.02% 607
2014
Q4
$5.04M Buy
51,912
+5,153
+11% +$477K 0.03% 545
2014
Q3
$3.65M Buy
46,759
+26,650
+133% +$1.72M 0.02% 655
2014
Q2
$1.27M Buy
+20,109
New +$1.2M 0.01% 1140

Other funds holding ALNY

Ohio Public Employees Retirement System (OPERS)'s ALNY Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) reduced its Alnylam Pharmaceuticals (ALNY) stake by 14% in Q2 2026, selling an estimated $1.82M and leaving 37,998 shares worth $11.4M. The position accounts for 0.03% of the portfolio, ranked #426.

Ohio Public Employees Retirement System (OPERS) first reported a position in ALNY in Q2 2014 and has held it in 49 quarters since. The position peaked at $17.8M in Q3 2025. 784 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) held 37,998 shares of Alnylam Pharmaceuticals worth $11.4M as of Q2 2026.
  • Ohio Public Employees Retirement System (OPERS) sold 6,024 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $1.82M.
  • Alnylam Pharmaceuticals made up 0.03% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #426 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Alnylam Pharmaceuticals in Q2 2014 and has held it in 49 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Alnylam Pharmaceuticals position peaked at $17.8M in Q3 2025.
  • 784 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.